Dimitris Mavroudis
Overview
Explore the profile of Dimitris Mavroudis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2854
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makrakis D, Rounis K, Tsigkas A, Georgiou A, Galanakis N, Tsakonas G, et al.
PLoS One
. 2023 Feb;
18(2):e0277708.
PMID: 36763597
Obesity and sarcopenia have been reported to affect outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). We analyzed prospective data from 52 patients...
2.
Rounis K, Makrakis D, Gioulbasanis I, Ekman S, De Petris L, Mavroudis D, et al.
Life (Basel)
. 2022 Jun;
12(6).
PMID: 35743911
Cancer cachexia syndrome (CCS) is a multifactorial metabolic syndrome affecting a significant proportion of patients. CCS is characterized by progressive weight loss, alterations of body composition and a systemic inflammatory...
3.
Foukakis T, Matikas A, Oikonomidou O, Andreopoulou E, Mavroudis D
Breast Care (Basel)
. 2021 Oct;
16(4):422-428.
PMID: 34602950
No abstract available.
4.
Chantziou A, Theodorakis K, Polioudaki H, de Bree E, Kampa M, Mavroudis D, et al.
Int J Mol Sci
. 2021 Aug;
22(15).
PMID: 34360932
In breast cancer, expression of Cluster of Differentiation 24 (CD24), a small GPI-anchored glycoprotein at the cell periphery, is associated with metastasis and immune escape, while its absence is associated...
5.
Strati A, Zavridou M, Kallergi G, Politaki E, Kuske A, Gorges T, et al.
Clin Chem
. 2021 Jul;
67(10):1395-1405.
PMID: 34322698
Background: Circulating tumor cell (CTC) analysis is highly promising for liquid biopsy-based molecular diagnostics. We undertook a comprehensive molecular analysis of in vivo isolated CTCs in breast cancer (BrCa). Methods:...
6.
Polioudaki H, Mala A, Gkimprixi E, Papadaki M, Chantziou A, Tzardi M, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33322610
We aimed to evaluate the co-expression of PD-L1 and epithelial-mesenchymal markers in CTCs from metastatic breast cancer (MBC) patients and to determine if there is any relationship with patients' outcome...
7.
Skribek M, Rounis K, Makrakis D, Agelaki S, Mavroudis D, De Petris L, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33321730
There is lack of data addressing the intracranial (IC) efficacy of immune checkpoint inhibitors (ICIs) on brain metastases (BM) in non-small cell lung cancer (NSCLC). This patient category is underrepresented...
8.
Apostolou P, Fostira F, Kouroussis C, Kalfakakou D, Delimitsou A, Agelaki S, et al.
Int J Cancer
. 2020 Feb;
147(5):1334-1342.
PMID: 32022259
Germline BRCA1 and BRCA2 loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek...
9.
Thomopoulou K, Manolakou S, Messaritakis I, Tzardi M, Lagoudaki E, Koutsopoulos A, et al.
Ann Gastroenterol
. 2020 Jan;
33(1):95-97.
PMID: 31892804
Despite the development of new treatment options based on the molecular characterization of colorectal cancer, 20% of patients present de novo metastatic disease, whereas 30-40% of patients who receive curative...
10.
Dork T, Peterlongo P, Mannermaa A, Bolla M, Wang Q, Dennis J, et al.
Sci Rep
. 2019 Aug;
9(1):12524.
PMID: 31467304
Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer...